@article{fae998bed80648efab1979aa6a296523,
title = "New TAVR Devices: European Experience and Status of US Trials",
author = "BM Jones and A Krishnaswamy",
note = "T he last decade has witnessed an incredible transformation in transcatheter therapies for valvular heart disease, from early clinical trials to widespread clinical application. Transcatheter aortic valve replacement (TAVR) has become the standard of care for appropriately selected inoperable patients with severe aortic stenosis, has shown equal or superior results as compared with surgical aortic valve replacement for high-risk patients, and has shown promising early results in intermediate-risk populations.",
year = "2016",
language = "American English",
journal = "Cardiac Interventions Today",
}